Sagimet Bioscience’s denifanstat, a one-daily pill for the treatment of acne, has succeeded in a Phase III trial, with the biotech’s license partner Ascletis Bioscience set to submit the drug for ...
-Phase III trial enrolled a total of 480 patients with moderate to severe acne-Topline results expected in the second quarter 2025 This Phase III clinical trial is a randomized, double-blind, ...
"Spironolactone is used more widely in North America and produces good clinical results, especially for female adult acne or acne in the context of PCOS (polycystic ovary syndrome)," adds Dr Mahto, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results